Dermatomyositis–lupuslike syndrome overlap under treatment with etanercept for rheumatoid arthritis

• Anna Lyakhovitsky, MD,
• Karin Warshavsky, MD,
• Lihi Rozner, MD,
• Theodoulos Drousiotis, MD,
• Sharon Baum, MD,
• Aviv Barzilai, MSc, MD

Affiliations

Anna Lyakhovitsky, MD

Department of Dermatology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Correspondence to: Anna Lyakhovitsky, MD, Sheba Medical Center, Dermatology Department, Tel-Hashomer, Ramat-Gan, Israel.

Karin Warshavsky, MD

Department of Dermatology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Lihi Rozner, MD

Department of Dermatology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Theodoulos Drousiotis, MD

Department of Dermatology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Sharon Baum, MD

Department of Dermatology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Aviv Barzilai, MSc, MD

Department of Dermatology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel; Institute of Pathology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel